Clinical Trial Update: Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing standard injections to reduced injections of intravesical onabotulinumtoxinA for overactive bladder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Overactive Bladder | Phase 4 | Status: RECRUITING